BNP Paribas Financial Markets’s Enliven Therapeutics ELVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$74.7K Buy
3,722
+930
+33% +$18.7K ﹤0.01% 3302
2025
Q1
$54.9K Sell
2,792
-2,199
-44% -$43.3K ﹤0.01% 3430
2024
Q4
$112K Buy
+4,991
New +$112K ﹤0.01% 3278